Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study
Background: Guideline-directed medical therapy in patients with systolic heart failure (HF) has demonstrated improvement in morbidity and mortality rates. The FDA approved sacubitril/valsartan in 2015 to reduce the risk of cardiovascular death and hospitalization for HF. Objective: The purpose of...
Saved in:
Main Authors: | Roda Plakogiannis, Abraham Stefanidis, Nubriel Hernandez, Etty Vider |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2025-02-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/6428 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity
by: Evelyn F Okal, et al.
Published: (2025-02-01) -
The SGLT-2 Inhibitors and their Role in the Treatment of Heart Failure - A Review of Literature
by: Silvia Ciraolo, et al.
Published: (2025-02-01) -
Two decades of recipient and donor referrals for heart transplantation to Groote Schuur Hospital, Cape Town, South Africa: A retrospective study
by: R Kanyongo, et al.
Published: (2024-04-01) -
Regular exercise in adolescents with ACE gene polymorphism helps preventing cardiovascular risk factors
by: Nivaldo de Jesus Silva Soares Junior, et al.
Published: (2025-02-01) -
Challenges in advanced heart failure care in Japan: Bridging the gap in durable mechanical circulatory support utilization and heart transplantation
by: Satoshi Miyashita, MD, et al.
Published: (2025-02-01)